11.00 - 13.00
11.00 - 11.09
11.09 - 11.18
11.18 - 11.27
11.27 - 11.36
11.36 - 11.45
11.45 - 11.54
11.54 - 12.03
12.03 - 12.12
12.12 - 12.21
12.21 - 12.30
12.30 - 12.39
12.39 - 12.48
12.48 - 13.00
SPECIALTY
COMMITTEE UPDATES
Translational research committee: Biology
Translational research committee: Circulating biomarker
Translational research committee: Molecular monitoring
Translational research committee: Pathology and bone marrow
Translational research committee: Immunotheray
New drug development
Local control and imaging: Nuclear medicine
Local control and imaging: Radiology
Local control and imaging: Radiotherapy
Local control and imaging: Surgery
Long term follow-up
Clinical Trial Committee
Finance Steering Committee
LARGE ROOM
16.30 - 17.30
16:30 - 16:40
16:40 - 16:50
16:50 - 16:55
16:55 - 17:05
17:05 - 17:15
17:15 - 17:25
17:25 - 17:30
LINES AND
PERSPECTIVES
LINES Low Risk: Where are we now?
LINES Intermediate Risk: Where are we now?
Suprarenal Masses
G8 Group Study
GPOH Guidelines/Trial
SIOPEN Non-High Risk Future Strategy
Discussion
LARGE ROOM